In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Eli Lilly & Co (LLY – ...

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

We recently compiled a list of the 10 Best Counter Cyclical and Defensive Stocks to Invest In. In this article, we are going ...

Although Lilly started consistently raising its dividend in 2015, investors should be aware of some details around the schedule of these payments. Every year since then, Lilly announced a hike to its ...

Eli Lilly and Company has announced the FDA approval of EBGLYSS for treating atopic dermatitis in adults and children over 12 ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other Jim Cramer’s best stocks for investors. In a recent episode of Mad Money, Jim Cramer ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 589.06% and ...

Eli Lilly and Company has ... served as CFO for several of the company’s global business areas. “One piece of advice I give new hires or people starting their career is to keep a flexible ...

The medication is an injectable branded Ebglyss and will be available in the next few weeks, the company ... their symptoms with topical medicines or other systemic treatments, Eli Lilly said.

BMO Capital Markets increased their price target on shares ... Receive News & Ratings for Eli Lilly and Company Daily - Enter your email address below to receive a concise daily summary of the ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 607.25% and currently trading at $935.06.The company has been around since 1876 and ...